Related Experiment Video

Updated: Aug 12, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia

Jonathan Isaacsohn1, Donald Hunninghake, Helmut Schrott

  • 1Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio, USA.

Clinical Cardiology
|January 24, 2003
PubMed

Insights

Simvastatin effectively lowers triglycerides and improves lipid profiles in patients with hypertriglyceridemia. This study shows simvastatin

Area of Science:

  • Cardiology
  • Pharmacology
  • Metabolic Disorders

Background:

  • Elevated triglycerides (TG) are linked to cardiovascular disease and other lipid abnormalities.
  • The efficacy of statins in hypertriglyceridemia is not well-established.
  • Hypertriglyceridemia management is crucial for reducing cardiovascular risk.

Purpose of the Study:

  • To assess the effectiveness of simvastatin in altering lipoprotein levels.
  • To evaluate simvastatin's impact on lipid profiles in hypertriglyceridemic patients.

Main Methods:

  • Multicenter, randomized, double-blind, placebo-controlled trial.
  • 195 patients with TG levels 300-900 mg/dl.
  • Daily simvastatin (20, 40, 80 mg) or placebo for 6 weeks.

Main Results:

  • Simvastatin significantly reduced TG levels by 20-31% compared to placebo.
  • Significant reductions observed in LDL-C (-25 to -35%) and non-HDL-C (-26 to -40%).
  • HDL-C levels increased by 7-11% with simvastatin treatment.

Conclusions:

  • Simvastatin demonstrates beneficial effects on lipid profiles in hypertriglyceridemic patients.
  • These findings support simvastatin's role in managing hypertriglyceridemia.
  • Simvastatin offers a potential therapeutic option for patients with elevated triglycerides.
Abstract

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...